Mercaptopropionylglycine: a progress in cystine stone therapy.
During a 4-year period 9 cases of severe recurrent cystine stones and cystinuria were treated with mercaptopropionylglycine. The oral long-term administration revealed the high effectiveness of the drug and resulted in no further stone formation. Mercaptopropionylglycine is free of side effects and more effective than D-penicillamine.
D000328:Adult; D000603:Amino Acids, Sulfur / Q000627:therapeutic use*; D003553:Cystine; D003555:Cystinuria / Q000188:drug therapy*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D010396:Penicillamine / Q000627:therapeutic use; D008625:Tiopronin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D014545:Urinary Calculi / Q000188:drug therapy*
D000603:Amino Acids, Sulfur; D003553:Cystine; D008625:Tiopronin; D010396:Penicillamine